Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
When facing a cancer diagnosis, understanding the process of Diagnosis and Staging is the first step toward a successful outcome. At Liv Hospital, our multidisciplinary team combines state‑of‑the‑art technology with personalized care to provide clear, accurate staging that guides every treatment decision. Each year, thousands of patients travel to Istanbul for advanced cancer assessment, and more than 85 % report confidence in their treatment plan after a comprehensive staging work‑up.
This page explains the essential components of cancer diagnosis and staging, the imaging and pathology tools we employ, how we coordinate care across borders, and what patients can expect during follow‑up. Whether you are preparing for cryotherapy, surgery, or systemic therapy, a precise stage classification empowers you and your physicians to choose the most effective, least invasive approach.
Read on to discover how Liv Hospital’s international patient services streamline the entire journey—from the moment you arrive in Turkey to the point when you return home with a clear, actionable treatment roadmap.
Accurate Diagnosis and Staging forms the foundation of modern oncology. Diagnosis confirms the type of cancer through tissue sampling, while staging determines the extent of disease spread. Together, they define prognosis, inform therapeutic options, and enable enrollment in clinical trials.
Liv Hospital follows the latest AJCC (American Joint Committee on Cancer) guidelines, ensuring that every patient receives a stage designation that aligns with international standards. This uniformity is especially important for patients traveling from abroad, as it simplifies communication with their home‑country physicians.
By clearly defining the stage, we can tailor the intensity of treatment, avoid unnecessary procedures, and improve overall survival.
Modern imaging provides a three‑dimensional map of the disease, making it indispensable for Diagnosis and Staging. At Liv Hospital we employ a full suite of modalities, each selected for its ability to reveal specific tumor characteristics.
Our radiology department integrates artificial intelligence algorithms that assist radiologists in measuring tumor volume and detecting subtle changes over time. This precision reduces inter‑observer variability and accelerates the staging workflow.
For cryotherapy candidates, we place special emphasis on high‑resolution MRI to delineate tumor margins, ensuring that the frozen zone will fully encompass the lesion while sparing healthy tissue.
Beyond imaging, Diagnosis and Staging rely heavily on pathological analysis. Tissue samples undergo a series of tests that reveal not only the cancer type but also its genetic drivers.
When appropriate, we perform next‑generation sequencing (NGS) panels that uncover actionable mutations (e.g., EGFR, KRAS, BRAF). These molecular insights can shift a patient from a standard stage‑based protocol to a targeted‑therapy regimen, improving response rates and reducing toxicity.
All pathology reports are generated in English and reviewed with the patient’s international oncologist via secure teleconference, guaranteeing seamless continuity of care.
Liv Hospital convenes daily tumor board meetings where surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists discuss each case. This collaborative approach translates the data from Diagnosis and Staging into a coherent, patient‑specific treatment plan.
For international patients, we record the session and provide a translated summary within 24 hours of the meeting. This transparency helps patients make informed decisions despite the distance.
Effective communication is a cornerstone of accurate Diagnosis and Staging, especially when patients travel from different time zones and language backgrounds.
Our patient liaison team prepares a personalized “Staging Summary” booklet that outlines the stage, recommended therapies, and timelines. This booklet is also translated into the patient’s native language, reducing anxiety and ensuring clarity.
Staging is not a one‑time event; it evolves as the disease responds to therapy. After the initial treatment plan derived from Diagnosis and Staging, we schedule systematic re‑evaluation to detect residual disease or recurrence.
When re‑staging indicates progression, our team promptly revises the treatment plan, offering options such as second‑line systemic therapy, additional cryotherapy sessions, or enrollment in clinical trials.
Liv Hospital combines JCI accreditation, cutting‑edge technology, and a dedicated international patient program to deliver world‑class cancer care. Our experts have extensive experience in cryotherapy, robotic surgery, and personalized oncology, ensuring that every step—from Diagnosis and Staging to post‑treatment follow‑up—is handled with precision and compassion. International patients benefit from coordinated logistics, multilingual support, and transparent communication, making their journey as smooth as possible.
Ready to take the next step toward a clear, personalized cancer treatment plan? Contact our International Patient Services team today to schedule a virtual consultation and begin your journey with Liv Hospital.
Send us all your questions or requests, and our expert team will assist you.
Cancer diagnosis involves obtaining tissue samples to identify the exact tumor type and its biological characteristics. Staging, most commonly using the TNM system, assesses tumor size, nodal involvement, and distant metastasis. Together they provide a complete picture of disease extent, which is essential for selecting appropriate therapies, estimating survival rates, and determining eligibility for clinical trials. Accurate staging also helps avoid overtreatment and reduces unnecessary procedures. At Liv Hospital, both steps follow AJCC guidelines to ensure consistency for international patients. The information is shared with the patient’s home‑country oncologist to maintain continuity of care.
The imaging workflow starts with a contrast‑enhanced CT scan to evaluate the chest, abdomen and pelvis for lymph node enlargement and organ involvement. MRI is employed for superior soft‑tissue contrast, especially in brain, spinal cord and pelvic cancers, providing high‑resolution images of tumor margins. PET‑CT adds metabolic information, revealing occult metastases that may not be seen on anatomic scans. Ultrasound assists in real‑time biopsy guidance and assessment of superficial lesions. Liv Hospital integrates artificial‑intelligence algorithms that automatically segment tumors, calculate volumes and detect subtle changes over time, which reduces inter‑observer variability and speeds up the staging process. For cryotherapy candidates, high‑resolution MRI is emphasized to precisely delineate the area to be treated.
After a biopsy, the tissue undergoes Hematoxylin & Eosin staining to assess cellular architecture and grade. Immunohistochemistry detects protein markers such as HER2, PD‑L1 or hormone receptors, which can influence treatment decisions. Fluorescence in situ hybridization identifies chromosomal rearrangements like ALK or ROS1 fusions. When indicated, next‑generation sequencing panels analyze dozens of genes to uncover mutations (e.g., EGFR, KRAS, BRAF) that may qualify the patient for targeted therapies. All pathology reports are generated in English and reviewed with the patient’s external oncologist via secure teleconference, ensuring that molecular findings are incorporated into the staging and treatment plan.
Once staging is complete, the case is presented at Liv Hospital’s tumor board, which includes surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists. The team discusses the stage, any ambiguities, and the patient’s overall health and preferences. Consensus is reached on the optimal therapeutic sequence—such as neoadjuvant therapy followed by surgery and adjuvant cryotherapy. Recommendations are documented in a unified report and shared with the patient and their home‑country physician within 24 hours, often accompanied by a translated summary. This collaborative approach ensures that the plan aligns with international standards and the patient’s individual circumstances.
International patients benefit from professional medical interpreters in more than 20 languages, ensuring clear communication during every appointment. A secure digital health portal allows patients to upload imaging, pathology slides and consent forms before arrival, speeding up the work‑up. The hospital coordinates airport transfers, hotel reservations and visa guidance to simplify travel. After treatment, remote monitoring tools enable clinicians to track recovery, and follow‑up tele‑visits provide ongoing clinical assessment. A personalized “Staging Summary” booklet, translated into the patient’s native language, outlines the stage, recommended therapies and timelines, reducing anxiety and improving understanding.
BlogCancerFeb 19, 2026When a tumor gets cryoablation therapy, it faces extremely low temperatures. This makes the cancer cells fr...
BlogCancerOct 30, 2025Cryosurgery, also known as cryogenic surgery, is a treatment that uses cold temperatures to kill abnormal o...
BlogCancerOct 30, 2025At Liv Hospital, we use advanced cryoablation technology to treat different types of cancer. This includes ...
BlogCancerOct 30, 2025At Liv Hospital, we use cryosurgery to fight cancerous tissue with extreme cold. This method is minimally i...
BlogCancerOct 30, 2025At Liv Hospital, we focus on new and safe treatments like cryotherapy. It’s a way to fight cancer wit...
BlogCancerOct 30, 2025If you or a loved one are looking into new cancer treatments, Liv Hospital offers patient-centered care. We...
